Pharmacogenetics of lithium response in bipolar disorder

Journal of Psychiatry and Neuroscience

Volumn 24, Issue 2, 1999, Pages 154-158

  Alda, Martin ^a,b  

^a DALHOUSIE UNIVERSITY   (Canada)

^b Abbie J Lane Building ^*  (Canada)

Author keywords

Association; Bipolar disorder; Family; Genetics; Linkage (genetics); Lithium; Pharmacogenetics

Indexed keywords

LITHIUM;

DRUG EFFICACY; FAMILY HISTORY; GENETIC LINKAGE; HUMAN; MANIC DEPRESSIVE PSYCHOSIS; PHARMACOGENETICS; PREDICTION; REVIEW; TREATMENT OUTCOME;

ANTIMANIC AGENTS; BIPOLAR DISORDER; HUMANS; LITHIUM;

EID: 0032895330     PISSN: 11804882     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (36)

1. Dorus E, Pandey GN, Davis JM. Genetic determinant of lithium ion distribution: an in vitro and in vivo monozygotic-dyzygotic twin study. Arch Gen Psychiatry 1975;32:1097-102.
2. Dorus E, Cox NJ, Gibbons RD, Shaughnessy R, Ghanshyam NP, Cloninger R. Lithium ion transport and affective disorders within families of bipolar patients: identification of a major gene locus. Arch Gen Psychiatry 1983;40:545-52.
3. Hasstedt SJ, Hunt SC, Wu LL, Williams RR. Evidence for multiple genes determining sodium transport. Genet Epidemiol 1994;11:553-68.
4. Elizur A, Shopsin B, Gershon S, Ehlenberger A. Intra:extra cellular lithium ratios and clinical course in affective states. Clin Pharmacol Ther 1972;13:947-52.
5. Mendels J, Frazer A. Intracellular lithium concentration and clinical responses: towards a membrane theory of depression. J Psychiatr Res 1973;10:9-18.
6. Dorus E, Pandey GN, Schaughnessy R, Gaviria M, Val E, Ericksen S, et al. Lithium transport across red cell membrane: a cell membrane abnormality in manic-depressive illness. Science 1979;205:932.
7. Richelson E, Snyder K, Carlson J, Johnson M, Turner S, Lumry A, et al. Lithium ion transport by erythrocytes of randomly selected blood donors and manic-depressive patients: lack of association with affective illness. Am J Psychiatry 1986;143:457-62.
8. Rybakowski J, Strzyzewski W. Red blood cell lithium index and long term maintenance treatment. Lancet 1976;2:1408.
9. Grof P, Lane J, MacCrimmon D, Werstuik E, Blajchman M, Daigle L, et al. Clinical and laboratory correlates of the response to long-term lithium treatment. In: Schou M, Stromgren E, editors. Origin, prevention and treatment of affective disorders. London: Academic Press; 1979. p. 27-40.
10. Kocsis JH, Kantor JS, Lieberman KW, Stokes PE. Lithium ratio and maintenance treatment response. J Affect Disord 1982;4:213-8.
11. Rihmer Z, Arato M, Szentistvanyi I, Banki CM. The red blood cell/plasma lithium ratio: marker of biological heterogeneity within bipolar affective illness? Psychiatry Res 1982;6:197-201.
12. Yassa R, Nair V. Prophylaxis and the lithium ratio in bipolar patients. Prog Neuropsychopharmacol Biol Psychiatry 1985;9:423-28.
13. Hewick DS, Murray N. Red-blood-cell levels and lithium toxicity. Lancet 1976;1(7982):473.
14. Foster JR, Silver M, Boksay IJE. Lithium in the elderly: a review with special focus on the use of intra-erythrocyte (RBC) levels in detecting serious impending neurotoxicity. Int J Geriatr Psychiatry 1990;5:1-7.
15. De Maio D, Buffa G, Riva M, Laviani M, Levi-Minzi A. Lithium ratio, phospholipids and the incidence of side effects. Prog Neuropsychopharmacol Biol Psychiatry 1994;18:285-93.
16. Strickland TL, Lin K, Fu P, Anderson D, Zheng Y. Comparison of lithium ratio between African-American and Caucasian bipolar patients. Biol Psychiatry 1995;37:325-30.
17. Yassa R, Nair V, Kraus DJ. A possible indication for red cell lithium determinations: a case report. Can J Psychiatry 1984;29: 44-5.
18. Grof P, Alda M, Grof E, Fox D, Cameron P. The challenge of predicting response to stabilising lithium treatment. The importance of patient selection. Br J Psychiatry 1993;(Suppl 21): 16-9.
19. Grof P, Alda M, Grof E, Zvolsky P, Walsh M. Lithium response and genetics of affective disorders. J Affect Disord 1994;32:85-95.
20. Alda M, Grof P, Grof E. MN blood groups and bipolar disorder: evidence of genotypic association and Hardy-Weinberg disequilibrium. Biol Psychiatry 1998;44:361-3.
21. Weder AB, Schork NJ, Julius S. Linkage of MN locus and erythrocyte lithium-sodium countertransport in Tecumseh, Michigan. Hypertension 1991;17:977-81.
22. Mendlewicz J, Fieve RR, Stallone F. Relationship between the effectiveness of lithium therapy and family history. Am J Psychiatry 1973;130:1011-3.
23. McKnew DH, Cytryn L, Buchsbaum MS, Hamovit J, Lamour M, Rapoport JL, et al. Lithium in children of lithium-responding parents. Psychiatry Res 1981;4:171-80.
24. Dunner DL, Fleiss JL, Fieve RR. Lithium carbonate prophylaxis failure. Br J Psychiatry 1976;129:40-4.
25. Misra PC, Bums BH. "Lithium nonresponders" in a lithium clinic. Acta Psychiatr Scand 1977;55:32-40.
26. Engström C, Åström M, Nordqvist-Karlsson B, Adolfsson R, Nylander P. Relationship between prophylactic effect of lithium therapy and family history of affective disorders. Biol Psychiatry 1997;42:425-33.
27. Smeraldi E, Petroccione A, Gasperini M, Macciardi F, Orsini A, Kidd KK. Outcomes on lithium treatment as a tool for genetic studies in affective disorders. J Affect Disord 1984;6:139-51.
28. Duffy A, Grof P, Grof E, Zvolsky P, Alda M. Evidence supporting the independent inheritance of primary affective disorders and primary alcoholism in the families of bipolar patients. J Affect Disord 1998;50:91-6.
29. Alda M, Grof P, Grof E, Zvolsky P, Walsh M. Mode of inheritance in families of patients with lithium-responsive affective disorders. Acta Psychiatr Scand 1994;90:304-10.
30. Alda M, Grof E, Cavazzoni P, Duffy A, Martin R, Ravindran L, et al. Autosomal recessive inheritance of affective disorders in families of responders to lithium prophylaxis? J Affect Disord 1997;44:153-57.
31. Duffy A, Alda M, Kutcher S, Fusee C, Grof P. Psychiatric symptoms and syndromes among adolescent children of parents with lithium-responsive or lithium-nonresponsive bipolar disorder. Am J Psychiatry 1998;155(3):431-3.
32. Cavazzoni P, Alda M, Turecki G, Rouleau G, Grof E, Martin R, et al. Lithium-responsive affective disorders: no association with the tyrosine hydroxylase gene. Psychiatry Res 1996;64:91-6.
33. Turecki G, Alda M, Grof P, Grof E, Martin R, Cavazzoni PA, et al. No association between chromosome-18 markers and lithium responsive affective disorders. Psychiatry Res 1996;63:17-23.
34. Turecki G, Martin RB, Cavazzoni P, Duffy A, Grof E, Grof P, et al. Lithium-responsive bipolar disorder and chromosome 18 [abstract]. Am J Med Genet (Neuropsychiatr Genet) 1997;74(6):676.
35. Berrettini WH, Ferraro TN, Goldin LR, Weeks DE, Detera-Wadleigh S, Nurnberger JI, et al. Chromosome 18 DNA markers and manic-depressive illness: evidence for a susceptibility gene. Proc Natl Acad Sci U S A 1994;91:5918-21.
36. Turecki G, Grof P, Cavazzoni P, Duffy A, Grof E, Ahrens B, et al. Preliminary evidence for a role of phospholipase C-y1 in the pathogenesis of bipolar disorder. Mol Psychiatry 1998;3:534-8.